✦ LIBER ✦

Assessment of use of Glycoprotein IIb/IIIa receptor antagonists in patients undergoing percutaneous coronary interventions

✍ Scribed by K.J. Shah*; K.H. Parikh; M.C. Chag; U.G. Shah; A.H. Chandarana; H.A. Baxi; A.M. Naik; Ramesh K. Goyal

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glycoprotein IIb/IIIa Antagonists in the

✍ UMESH K. ARORA; IAN CONDE; NEAL S. KLEIMAN 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 893 KB

Efficacy and safety of glycoprotein IIb/

✍ Loic Belle; Magali Fourny; Thomas Reynaud; Laure Hammer; Gérald Vanzetto; José L 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

Planned Versus Provisional Use of Glycop

✍ Jason O. Robertson; A. Michael Lincoff; Kathy Wolski; Eric J. Topol 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Trials of platelet glycoprotein IIb/IIIa

✍ A.Michael Lincoff 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Effect of intravenous glycoprotein IIb/I

✍ F. Aslam 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Meta-analysis of survival with platelet

✍ David F Kong; Vic Hasselblad; Robert A Harrington; Harvey D White; James E Tchen 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 154 KB